Home
Conditions
Myelodysplasia

Clinical trial condition

Myelodysplasia

Explore clinical trials studying Myelodysplasia. Study availability and eligibility vary by location and protocol.

43 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplasia trial results

Completed

Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath

NCT00578942

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations: Duke University Health Systems Durham, North Carolina, United States

View Trial Details

Completed

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

NCT01933035

Conditions: Anemia, Anemia, Aplastic, Anemia, Refractory, +26 more
Locations: Roosevelt Hospital New York, United States

View Trial Details

Completed

Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant

NCT01904175

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +19 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer

NCT00975975

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Anemia, +47 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia

NCT02007863

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Anemia, +18 more
Locations: Jackson Memorial Hospital Miami, Florida, United States

University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States

View Trial Details

Completed

Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy

NCT00990587

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +39 more
Locations: Vancouver General Hospital Vancouver, British Columbia, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath

NCT00580034

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations: Duke University Health Systems Durham, North Carolina, United States

View Trial Details

Completed

Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant

NCT00597714

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +19 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants

NCT00606437

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +21 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Allogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional Study

NCT01095874

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +5 more
Locations: Hôpital Saint-Louis Paris, France

View Trial Details

Myelodysplasia

Myelodysplasia trial results

Related conditions